BSE Live
Jan 23, 16:01Prev. Close
1418.40
Open Price
1418.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:50Prev. Close
1417.90
Open Price
1425.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1376.40 (1)
| Key Financial Ratios of Dr Lal PathLabs (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 27.42 | 24.19 | 20.85 | 19.02 | 16.09 | |
| Diluted EPS (Rs.) | 27.37 | 24.15 | 20.82 | 18.95 | 15.98 | |
| Cash EPS (Rs.) | 36.04 | 28.64 | 24.58 | 22.05 | 19.54 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 126.48 | 114.11 | 95.00 | 71.99 | 61.63 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 126.48 | 114.11 | 95.00 | 71.99 | 61.63 | |
| Revenue from Operations/Share (Rs.) | 159.63 | 144.40 | 126.83 | 109.84 | 95.71 | |
| PBDIT/Share (Rs.) | 47.83 | 40.75 | 35.43 | 31.91 | 25.97 | |
| PBIT/Share (Rs.) | 39.09 | 36.16 | 31.46 | 28.59 | 22.55 | |
| PBT/Share (Rs.) | 37.25 | 36.06 | 31.36 | 28.51 | 24.28 | |
| Net Profit/Share (Rs.) | 27.31 | 24.05 | 20.61 | 18.73 | 16.11 | |
| NP After MI And SOA / Share (Rs.) | 27.10 | 23.90 | 20.49 | 18.61 | 15.99 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 29.96 | 28.22 | 27.93 | 29.05 | 27.13 | |
| PBIT Margin (%) | 24.48 | 25.04 | 24.80 | 26.03 | 23.56 | |
| PBT Margin (%) | 23.33 | 24.97 | 24.72 | 25.95 | 25.36 | |
| Net Profit Margin (%) | 17.10 | 16.65 | 16.25 | 17.05 | 16.83 | |
| NP After MI And SOA Margin (%) | 16.97 | 16.55 | 16.15 | 16.94 | 16.70 | |
| Return on Networth/Equity (%) | 21.86 | 21.06 | 21.67 | 25.95 | 26.09 | |
| Return on Capital Employed (%) | 28.40 | 31.65 | 32.78 | 25.54 | 24.73 | |
| Return on Assets (%) | 16.43 | 18.26 | 18.64 | 22.40 | 21.14 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 96.79 | 110.35 | 115.44 | 132.21 | 126.56 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 3.93 | 5.88 | 5.37 | 5.50 | 4.67 | |
| Quick Ratio (X) | 3.68 | 5.68 | 5.14 | 5.29 | 4.51 | |
| Inventory Turnover Ratio (X) | 23.34 | 42.17 | 38.67 | 50.95 | 54.52 | |
| Dividend Payout Ratio (NP) (%) | 56.52 | 27.46 | 18.51 | 23.81 | 15.33 | |
| Dividend Payout Ratio (CP) (%) | 42.75 | 23.04 | 15.50 | 20.21 | 12.63 | |
| Earnings Retention Ratio (%) | 43.48 | 72.54 | 81.49 | 76.19 | 84.67 | |
| Cash Earnings Retention Ratio (%) | 57.25 | 76.96 | 84.50 | 79.79 | 87.37 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 21.29 | 359.22 | 311.72 | 340.29 | -13.09 | |
| Interest Coverage Ratios (Post Tax) (%) | 21.29 | 359.22 | 311.72 | 340.29 | -13.09 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 11,132.07 | 8,303.66 | 6,979.84 | 7,799.56 | 7,391.93 | |
| EV/Net Operating Revenue (X) | 8.37 | 6.90 | 6.60 | 8.55 | 9.34 | |
| EV/EBITDA (X) | 27.93 | 24.45 | 23.64 | 29.43 | 34.42 | |
| MarketCap/Net Operating Revenue (X) | 8.78 | 7.30 | 6.90 | 8.81 | 9.63 | |
| Retention Ratios (%) | 43.47 | 72.53 | 81.48 | 76.18 | 84.66 | |
| Price/BV (X) | 11.31 | 9.30 | 9.25 | 13.50 | 15.04 | |
| Price/Net Operating Revenue | 8.78 | 7.30 | 6.90 | 8.81 | 9.63 | |
| Earnings Yield | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
05.12.2025
10.11.2025
Dr Lal PathLab Standalone September 2025 Net Sales at Rs 699.60 crore, up 19.82% Y-o-Y
31.10.2025
Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
10.11.2025
Dr Lal PathLab Standalone September 2025 Net Sales at Rs 699.60 crore, up 19.82% Y-o-Y
31.10.2025
Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
06.10.2021
Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher
18.01.2021
Dr. Lal PathLabs Q3 PAT seen up 27.4% YoY to Rs. 54.1 cr: Prabhudas Lilladher
11.10.2019
Dr Lal Pathlabs Q2 PAT seen up 48.8% YoY to Rs. 84.8 cr: Kotak
15.07.2019
Dr Lal Pathlabs Q1 PAT seen up 17.6% YoY to Rs. 58.1 cr: Kotak